SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN

Similar documents
Hemolytic anemias (2 of 2)

Anemia s. Troy Lund MSMS PhD MD

In adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains

DONE BY : RaSHA RAKAN & Bushra Saleem

Congenital Haemoglobinopathies

Sickle cell disease. Fareed Omar 10 March 2018

Thalassemia Maria Luz Uy del Rosario, M.D.

4 Jumana Jihad Dr. Ahmad Mansour Dr. Ahmad Mansour

How to Write a Life Care Plan for a Child with Hemoglobinopathy

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C.

Genetics of Thalassemia

Sickle Cell Disease and impact on the society

General Characterisctics

Corporate Medical Policy

Done by :Aseel Twaijer & Laith Sorour Hemolytic Anemias

Sickle Cell Disease. Edward Malters, MD

Red cell disorder. Dr. Ahmed Hasan

HEMOLYTIC ANEMIA DUE TO ABNORMAL HEMOGLOBIN SYNTHESIS

RBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY HEMOLYTIC ANEMIAS. Dr. Tariq Aladily

Introduction reduction in output alter the amino acid sequence combination

Educational Items Section

RBCs Disorders 2. Dr. Nabila Hamdi MD, PhD

- Ensherah Mokheemer. - Rama Nada. - Tareq Aladily. 1 P a g e

Dr.Abdolreza Afrasiabi

Screening for haemoglobinopathies in pregnancy

Heme Questions and Derivatives for the USMLE Step One Exam. Winter Storm Skylar Edition

Dr Banu Kaya Consultant Haematologist Barts Health NHS Trust Royal London Hospital, London, UK SICKLE CELL AND THALASSAEMIA OVERVIEW

HAEMOGLOBINOPATHIES. Editing file. References: 436 girls & boys slides 435 teamwork slides. Color code: Important. Extra.

Hypochromic Anaemias

Fetal Anemia 02/13/13. Anjulika Chawla, M.D. Assistant Professor Division of Pediatric Hematology/Oncology

Haemoglobinophaties EBMT 2011 Data Manager session

Medical and Surgical Complications of Sickle Cell Anemia

Thalassemias. Emanuela Veras, M.D. 01/08/2006

The Thalassemias in Clinical Practice. Ashutosh Lal, MD Director Comprehensive Thalassemia Program UCSF Benioff Children s Hospital Oakland

Transfusion support in Thalassaemia. Dr.A.keerti 1 st year PG DEPT. OF TRANSFUSION MEDICINE

Approach to Hemolysis

THALASSEMIA DEFINITION INHERITANCE BASICS 2014/03/04. THALASSA : GREEK WORD GREAT SEA First observed: MEDITTERANIAN SEA

THALASSEMIA AND COMPREHENSIVE CARE

RBCs Disorders 2. Dr. Nabila Hamdi MD, PhD

Comprehensive Hemoglobin Analysis HBA1/2 (

Hemoglobinopathies Diagnosis and management

An overview of Thalassaemias and Complications

Haemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD

Microcytic Hypochromic Anemia An Approach to Diagnosis

What is Thalassaemia?

Heme Questions and Derivatives for the USMLE Step One Exam. Winter Storm Skylar Edition

Pitfalls in the premarital testing for thalassaemia

Putting some hematology into Pediatric Hematology/Oncology: a review of Hemophilia and Sickle Cell Disease in the Pediatric Patient

Dr. Ayman Mohsen Mashi, MBBS Consultant Hematology & Blood Transfusion Department Head, Laboratory & Blood Bank King Fahad Central Hospital, Gazan,

CURRENT RESEARCH STUDIES

C. treatment with Desferal (deferoxamine mesylate USP, iron-chelating agent)

Anaemia in Pregnancy

World-Wide Distribution of Hemoglobin S. Geographic distribution of hemoglobin S in the world

Other labs 4/24/2012. N 24: Pediatric Hematological Alterations & Cancer Intro. Cabrillo College ADN Program C. Madsen RN, MSN 1.

1) Anemias Dr. Anwar Sheikha

HPLC profile of sickle cell disease in central India

DIC. Disseminated intravascular coagulation, is a life threatening pathological process in which clotting factors are abnormally activated.

Rationale for RBC Transfusion in SCD

Pediatrics. Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment. Definition. Epidemiology of Pyruvate Kinase Deficiency.

Dependance on chronic transfusion

Health Maintenance and Education for Children and Adults

Cover Page. The handle holds various files of this Leiden University dissertation.

Quiz. What percentage of the world s population is a carrier of a hemoglobinopathy? Hemoglobinopathies in Pregnancy 1-2% 5-7% 8-12% 10-15%

HEMOGLOBINOPATHIES LECTURE OUTLINE. An overview of the structure of hemoglobin. Different types of hemoglobin. Definition of hemoglobinopathies

Report of Beta Thalassemia in Newar Ethnicity

Disclosure. Hemoglobinopathies. Screening for Hemoglobinopthies. Learning Objectives. Screening for Hemoglobinopthies. Interpreting Reports

Genetic Modifiers of Sickle Cell Disease Severity. Kunle Adekile, MD, PhD Professor Department of Pediatrics Kuwait University

Epidemiology, Care and Prevention of Hemoglobinopathies

Hemoglobinopathies NORMAL HEMOGLOBINS

Genetic Testing for α-thalassemia

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

O 2 O 2 O 2. Haemoglobin

Medical Policy. MP Genetic Testing for α-thalassemia. Related Policies Preimplantation Genetic Testing

The Child with a Hematologic Alteration

FUNCTIONS OF HEMOGLOBIN:

A Counseling Guide for Sickle Cell and Other Hemoglobin Variants

Approach to a pale child

Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease

Guideline developed by Shelley Crary, MD, MS,* in collaboration with the ANGELS team. Last reviewed by Shelley Crary, MD, MS, January 19, 2017.

Congenital Hemolytic Anemias

4 Fahed Al Karmi Sufian Alhafez Dr nayef karadsheh

Year 2003 Paper two: Questions supplied by Tricia

Fig.No.1. Effect on RBCs

High Hemoglobin F in a Saudi Child Presenting with Pancytopenia

Chem*3560 Lecture 4: Inherited modifications in hemoglobin

HAEMOLYTIC ANAEMIA. Dr. Hasan Fahmawi, MRCP(London), FRCP(Edin) Consultant Physician

Clinical Characteristics of Pediatric Thalassemia in Korea: A Single Institute Experience

The Challenging Diagnosis of Treacherous Hemoglobinopathies

CRISPR-mediated Editing of Hematopoietic Stem Cells for the Treatment of β-hemoglobinopathies

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics

Hematology Unit Lab 1 Review Material

Non-malignant hematologic disorders associated arthropathies: hemoglobinopathy-associated musculoskeletal manifestations, hemophilia

Unraveling Hemoglobinopathies with Capillary Electrophoresis

6.1 Extended family screening

Susan Stegman, MD Medical Director AXA Equitable Life May 3, 2016

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Th e h a e m o g l o b i n o p a t h i e s r e s u l t i n a n a e m i a of varying severity due to reduced levels of globin

1 Kattamis et al. Growth of Children with Thalassemia: Effect of Different Transfusion Regimens. Archives of

Transcription:

SICKLE CELL DISEASE Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN

Objective: The student should be able: To identify the presentation, diagnosis, management and long term complications of Sickle Cell Disorder and Thalassemia.

Hemoglobin Synthesis Adult hemoglobin - 96% HgA (a 2 B 2 ) a 2 B2 a 2 B2

Hemoglobinopathies Abnormal Hb Structure (Qualitative) Hereditary Disorders >300 Types Abnormal Hemoglobin Hemoglobin S Disorders - Most Prevalent - Sickle Cell Disease - Homozygous (SS) - Sickle Cell Trait - Heterozygous

Hemoglobin S Disorders 6th GLU VAL HbA HbS Point Mutation of B Globin Gene Hb S Gene occurs in Africa and middle east.

Sickle Cell Disease Sickle cell Deoxygenation (or H 2 0, ph) Ca K, O 2 O 2 Polymerization of Hgb S

Sickle Cells

Clinical presentation Depends on severity of condition and age of the child. Hand foot syndrome in infants Pallor, jaundice, splenomegaly in young children Pallor, jaundice and no spleen in older children

Clinical presentation cont. Sickled cells are hemolyzed in the Spleen (young children- Splenomegaly) Micro vascular occlusion: - Tissue Infarcts and Pain - Auto-splenectomy (older children) - Infections - Salmonella Osteomyelitis

COMPLICATIONS Infections Vaso-occlusive effects (Acute chest syndrome) Cholecystitis Renal failure is common Neurological complications Leg ulcers

COMPLICATIONS cont. Crisis: Hemolytic Aplastic - Usually Parvovirus Infectious crisis Vaso-occlusive crisis Sequestration crisis

Diagnosis Sickling test In vitro sickling after adding Reducing Agent Hb electrophoresis to detect Hb S DNA Analysis - Prenatal Testing

TREATMENT Emergency Department Care: Administer oral hydration if the patient can tolerate oral fluids. Administer IV fluids Medications involved in treatment of sickle cell anemia include analgesics for pain and antibiotics for infections.

TREATMENT cont. In/Out Patient Meds: Folic acid. Discharge patient on oral analgesics for a week. Antibiotics when an infection is suspected. Hydroxyurea: Increases hemoglobin F. Hematopoietic stem cell transplantation

TREATMENT cont. Simple blood transfusion Aplastic crisis and acute sequestration crisis. Exchange blood transfusion Cerebrovascular accidents (CVA), acute chest syndrome. And occasionally in cases of priapism. ## Exchange transfusion consists of replacing the patient's RBCs by normal donor RBCs, decreasing HbS to less than 30%.

TREATMENT cont. Consultations: Ophthalmologist, if retinopathy is suspected and visual symptoms are present. Urologist in case of priapism that does not resolve after 6 hours. Orthopedist, if avascular necrosis of the hip or osteomyelitis is suspected. Surgery.

Thalassemia Absent or â Synthesis of Globin Chains (Quantitative) Most Frequent in Mediterranean, African and Asian Populations

Thalassemia β - Thalassemia - â β Chain Synthesis (Gene Mutations) α - Thalassemia - â α Chain Synthesis (1-3 of 4 Genes Deleted

Chromosome 16 α α α Silent carrier HbH disease α - Thalassemia α α α α α α - thalassemia trait (+/- anemia) (severe anemia) Hydrops fetalis (lethal in utero) Hb Bart

β - Thalassemia Minor β β β o β â β chain synthesis β β β + β â β chain synthesis Mild or no anemia

β - Thalassemia Major β β Chromosome 11 β β β o β o β + β + No β Chain Synthesis â β Chain Synthesis Severe Anemia

Clinical Presentation Anemia, jaundice, splenomegaly, prominent maxillary and frontal bones

Diagnosis Peripheral Blood Smear: - Target cells and basophilic stippled RBCs - Severe Hypochromic Microcytic Anaemia ( Hb A MCHC) Bone Marrow: - Erythroid Hyperplasia - Skeletal deformities Extra medullary Hematopoiesis - Splenomegaly and Hepatomegaly

Complications Growth Retardation Systemic Iron Overload (due to chronic blood transfusions) = Cirrhosis, Cardiomyopathy (Cardiac Failure), Death (2nd-3rd Decade)